Chart-Typ:
Zeitraum:
| AKTIEN IM FOKUS: Chipwerte unter Druck - ASML verunsichert für 2026 | FRANKFURT (dpa-AFX) - Europas Chipwerte haben am Mittwochmorgen nach vorsichtigen Geschäftssignalen von ASML kräftig Federn gelassen. Die Papiere des niederländischen Chipausrüsters selbst sackten... ► Artikel lesen |
| STMicroelectronics, Metalenz Enter New License Agreement To Accelerate Metasurface Optics Adoption | GENEVA (dpa-AFX) - STMicroelectronics (STM) and Metalenz announced a new license agreement. The agreement broadens ST's capability to use Metalenz IP to produce advanced metasurface optics
while... ► Artikel lesen |
| DEUTSCHE BANK RESEARCH stuft STMicro auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für STMicroelectronics von 30 auf 32 Euro angehoben und die Einstufung auf "Buy" belassen. Analyst Robert Sanders gab in seinem... ► Artikel lesen |
| VivoSim Labs, Inc.: VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market | SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company") announced that it has emerged from stealth mode to dramatically impact drug discovery and development.... ► Artikel lesen |
| Organovo, Inc.: Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements | SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches... ► Artikel lesen |
| Organovo, Inc.: Organovo Provides Business Update | SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches... ► Artikel lesen |
| INOVIO Pharma Announces Proposed Public Offering | WASHINGTON (dpa-AFX) - INOVIO Pharmaceuticals Inc. (INO) announced that it intends to offer and sell shares of its common stock (or pre-funded warrants to purchase its common stock in lieu thereof)... ► Artikel lesen |
| INOVIO Pharmaceuticals, Inc.: INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights | On track to begin rolling submission of Biologics License Application (BLA) for INO-3107 as a potential treatment for recurrent respiratory papillomatosis (RRP)... ► Artikel lesen |
| INOVIO Pharmaceuticals, Inc.: INOVIO Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights | Significant progress toward submitting a biologics license application (BLA) for INO-3107 as a potential treatment for recurrent respiratory papillomatosis (RRP)... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu STARDUST POWER INC finden Sie auf Wallstreet Online.